Gil D. Rabinovici mainly investigates Alzheimer's disease, Neuroscience, Pathology, Dementia and Atrophy. Specifically, his work in Alzheimer's disease is concerned with the study of Pittsburgh compound B. His research integrates issues of Corticobasal degeneration and Disease in his study of Neuroscience.
His Pathology course of study focuses on Precuneus and Early-onset Alzheimer's disease and Cardiology. His work carried out in the field of Dementia brings together such families of science as Apolipoprotein E and Degenerative disease. He has researched Atrophy in several fields, including Cerebral cortex, Biomarker, Alzheimer's Disease Neuroimaging Initiative and Central nervous system disease.
Gil D. Rabinovici spends much of his time researching Pathology, Disease, Alzheimer's disease, Dementia and Neuroscience. His Disease research is multidisciplinary, incorporating elements of Biomarker, Cognition and Neuroimaging. He combines subjects such as Positron emission tomography, Precuneus and Posterior cortical atrophy with his study of Alzheimer's disease.
His Dementia study incorporates themes from Cognitive impairment, Oncology, Psychiatry, Neurology and Amyloid. His is doing research in Default mode network and Human brain, both of which are found in Neuroscience. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Hyperintensity and Cardiology.
His main research concerns Disease, Dementia, Internal medicine, Cognition and Biomarker. The Disease study combines topics in areas such as Cerebral cortex, Neuroimaging and Distribution. His Dementia research is multidisciplinary, relying on both Odds ratio, Positron emission tomography, Cognitive impairment and Amyloid.
His Cognition study is concerned with the larger field of Neuroscience. His research in Neuroscience intersects with topics in Diaschisis and Primary progressive aphasia. Gil D. Rabinovici works mostly in the field of Alzheimer's disease, limiting it down to concerns involving Temporal lobe and, occasionally, Apolipoprotein E.
His primary areas of study are Disease, Tau pathology, Biomarker, Dementia and Comorbidity. His biological study spans a wide range of topics, including Cerebral cortex, Cognition, Neuroscience and Pathological staging. His Dementia research incorporates themes from Odds ratio, Cognitive impairment and Amyloid.
The various areas that Gil D. Rabinovici examines in his Odds ratio study include Medical diagnosis, Population ageing, Rate ratio, Alzheimer's disease and Positron emission tomography. His Cognitive impairment research entails a greater understanding of Pathology. His Amyloid study deals with the bigger picture of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura.
Nature Medicine (2007)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens.
Alzheimers & Dementia (2016)
Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease
Juan Zhou;Michael D. Greicius;Efstathios D. Gennatas;Matthew E. Growdon.
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz.
Movement Disorders (2017)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schöll;Michael Schöll;Samuel N. Lockhart;Daniel R. Schonhaut;James P. O’Neil.
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
E. C. Mormino;J. T. Kluth;C. M. Madison;G. D. Rabinovici;G. D. Rabinovici;G. D. Rabinovici.
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Rik Ossenkoppele;Rik Ossenkoppele;Rik Ossenkoppele;Daniel R. Schonhaut;Daniel R. Schonhaut;Michael Schöll;Michael Schöll;Samuel N. Lockhart.
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.
Gil D. Rabinovici;Bruce L. Miller.
CNS Drugs (2010)
Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
Gil D Rabinovici;William J Jagust;Ansgar J Furst;Ansgar J Furst;Jennifer M Ogar;Jennifer M Ogar.
Annals of Neurology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: